TopMarketGainers

$MRNS On watchlist for a breakout on impending news possibly .

NASDAQ:MRNS   MARINUS PHARMACEUTICALS INC
The price action has been quite positive in the stock of NASDAQ:MRNS in 2019 gaining almost 65% from the oversold lows in December. Like all Pharmaceutical companies, trails results can move the stock incredibly fast, speculation and rumor has it that the stock is due for a considerable breakout WITH PLENTY OF UPSIDE POTENTIAL. A alert for a break above the 200ma could signal a nice entry while using FIB retracement levels as good price targets.
SHORT INTEREST 9.44%
AVERAGE ANALYSTS PRICE TARGET $16.06
AVERAGE ANALYSTS RECOMMENDATION BUY

COMPANY PROFILE
Marinus Pharmaceuticals , Inc. is a biopharmaceutical company, which engages in the identification and development of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid.
Do you want to GAIN an Edge on Wall Street?

1) Sign Up for our Free Email Newsletter @
http://www.TopMarketGainers.com

2) Sign Up for our Free Text Message Notifications
by Texting 'GAINS' to 67076.

(*It's FREE, however Msg&Data rates may apply
Inicio Analizador de acciones Analizador de Forex Crypto Screener Calendario económico Cómo funciona Funcionalidades del gráfico Precios Normas Moderadores Soluciones broker y sitio web Widgets Soluciones gráficas Centro de ayuda Solicitud de funcionalidad Blog y Noticias Preguntas frecuentes Wiki Twitter
Perfil Opciones de configuración del perfil Cuenta y facturación Monedas TradingView Mis Tickets de Soporte Centro de ayuda Ideas publicadas Seguidores Siguiendo Mensajes privados Chat Cerrar sesión